The Future of Health is built on collaboration.


Last week at the Future of Health Congress, a simple but powerful truth was fully displayed: breakthroughs don’t happen in isolation. They are sparked by conversations in hallways, unexpected encounters, and open collaboration that turns ideas into impact.

Science alone isn’t enough to transform healthcare. Innovation doesn’t depend on cutting-edge technology or record-setting investments—it thrives in the right environment. At Leiden Bio Science Park, we see this every day. With more than 400 companies, world-class research institutions, and a deeply connected community, the foundation for progress isn’t just in the labs and offices. It’s in the people who meet, exchange ideas, and build something greater together.

At the congress, this idea became tangible. Leaders from across biotech, pharma, health tech, and AI weren’t just presenting research but forging partnerships. The most critical moments weren’t on stage but in the spaces in between—where a conversation over coffee might lead to the next big breakthrough. That’s the essence of orgware: not just the physical infrastructure of science, but the human network that makes innovation possible.

Seeing so many industry leaders sign their names to a shared commitment to the future of health was more than symbolic. It was a reminder that we create progress together—not through competition, but through connection. The future of health isn’t waiting to be discovered in a lab. It’s being built every day in the moments when the right people meet, challenge each other, and decide to push forward—together.

We’d like to thank everyone who attended and contributed to The Future of Health Congress.

 

Click here to view the aftermovie

 


  • LUMC opens dedicated CAR-T department

    Leiden University Medical Center (LUMC) has opened a dedicated department for CAR-T cell therapy, bringing care, research and expertise in this rapidly developing field together in one place. The new department, officially opened on 24 September, marks another step in…

  • VarmX recognised with two prestigious industry award nominations

    Leiden-based biotech company VarmX has received two industry award nominations recognising its scientific approach and strategic partnership with CSL. VarmX has been shortlisted for the 2026 Prix Galien USA “Best Startup” Award, which recognises early-stage companies developing novel therapeutic approaches.…